Moore Paul Andrew bought ZYME
January 5, 2026 · Form 4 insider transaction
Moore Paul Andrew bought 17,168 shares of Zymeworks Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,168
Price
$0.00
Total value
N/A
InsiderMoore Paul Andrew
RoleOfficer
CompanyZymeworks Inc. (ZYME)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 5, 2026
Filing dateJanuary 5, 2026
Shares owned after40,501
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on January 5, 2023.